Page last updated: 2024-09-05

opc 4392 and bifeprunox

opc 4392 has been researched along with bifeprunox in 1 studies

Compound Research Comparison

Studies (opc 4392)	Trials (opc 4392)	Recent Studies (post-2010) (opc 4392)	Studies (bifeprunox)	Trials (bifeprunox)	Recent Studies (post-2010) (bifeprunox)
16	1	0	30	1	12

Protein Interaction Comparison

Protein	Taxonomy	opc 4392 (IC50)	bifeprunox (IC50)
D(2) dopamine receptor	Homo sapiens (human)		0.0029

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Forbes, RA; Kikuchi, T; Kitagawa, H; McQuade, RD; Stark, A; Tadori, Y	1

Other Studies

1 other study(ies) available for opc 4392 and bifeprunox

Article	Year
Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912. European journal of pharmacology, 2007, Nov-28, Volume: 574, Issue:2-3 Topics: Animals; Aripiprazole; Benzoxazoles; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Humans; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Schizophrenia	2007

Article

Year

Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.

European journal of pharmacology, 2007, Nov-28, Volume: 574, Issue:2-3

Topics: Animals; Aripiprazole; Benzoxazoles; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Humans; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Schizophrenia

2007